Biosimilars

Need a refresher on biosimilars? Here, we offer some key points to keep in mind when it comes to structure, function, and interchangeability.

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Our free eBook showcases content on bioprocess scale up, biosimilars, primary packaging considerations, and more.

How can companies make their mark as the biosimilar market continues to grow?

Biosimilars have been available in Europe for years. Is the US still lagging behind?

Though in theory, biosimilars should help improve medicines access, what challenges still stand in the way of therapeutic equality and equity?

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.